Bezafibrate Capsule

Bezafibrate serves as a potent pan-PPAR agonist that simultaneously modulates alpha, gamma, and delta receptors to provide a synergistic regulatory effect on lipid metabolism and systemic glucose homeostasis. By effectively reducing serum triglycerides and very-low-density lipoproteins while elevating high-density lipoprotein levels, this medication significantly mitigates multifaceted cardiovascular risk factors in patients with mixed hyperlipidemia. The capsule delivery system is specifically engineered to optimize the pharmacokinetic profile of the active ingredient, ensuring consistent bioavailability and rapid disintegration for enhanced therapeutic efficacy and patient adherence.